查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1416342

基因轉殖技術市場報告：2030 年趨勢、預測與競爭分析

Gene Delivery Technologies Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

基因轉移技術的趨勢和預測

預計到 2030 年，全球基因轉殖技術市場將達到 77 億美元，2024 年至 2030 年複合年成長率為 14.6%。該市場的主要驅動力是慢性病盛行率的增加、對標靶治療的需求不斷成長以及遺傳和細胞研究以及治療方法交付的進步。全球基因轉殖技術市場的未來前景廣闊，基因治療、細胞治療、疫苗和研究市場充滿機會。

深入了解基因轉殖技術市場

Lucintel 預測，在 Kymriah 和 Yescarta 取得巨大成功後，由於基於病毒載體的研究和開發項目的增加，生物製品將在整個預測期內仍然是最大的細分市場。

在這個市場中，由於基因療法的採用越來越多以及臨床研究工作的數量不斷增加，基因療法將繼續成為最大的細分市場。

由於臨床試驗數量不斷增加、患者基因治療支出增加以及該地區領先公司的存在，北美在整個預測期內可能仍然是最大的地區。

常問問題

Q1.市場規模為：

A1. 到 2030 年，全球基因轉殖技術市場預計將達到 77 億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球基因轉殖技術市場預計將以14.6%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要驅動力是慢性病盛行率的增加、對標靶治療的需求不斷成長以及遺傳和細胞研究以及治療方法交付的進步。

Q4.市場的主要細分市場是：

A4. 基因轉殖技術市場前景廣闊，在基因治療、細胞治療、疫苗和研究市場都有機會。

Q5.市場的主要企業是：

A5. 一些主要的基因轉殖技術公司是：

  • Thermo Fisher Scientific
  • QIAGEN
  • Horizon Discovery
  • OriGene Technologies
  • Oxford Biomedica
  • SignaGen Laboratories
  • Vectalys

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，在 Kymriah 和 Yescarta 取得巨大成功之後，由於基於病毒載體的研發計劃的增加，生物製品將在整個預測期內保持其最大的細分市場。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於臨床試驗數量不斷增加、患者基因治療支出增加以及該地區領先公司的存在，預計北美仍將在整個預測期內保持最大的地區地位。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章 全球基因轉殖技術市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球基因轉殖技術市場趨勢（2018-2023）與預測（2024-2030）
  • 按模式分類的全球基因轉移技術市場
    • 生物
    • 科學的
    • 身體的
  • 按方法分類的全球基因轉移技術市場
    • 體外
    • 體內
    • 試管內
  • 按應用分類的全球基因轉殖技術市場
    • 基因治療
    • 細胞療法
    • 疫苗
    • 調查

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的全球基因轉殖技術市場
  • 北美基因轉殖技術市場
  • 歐洲基因轉殖技術市場
  • 亞太地區基因轉殖技術市場
  • 其他地區基因轉殖技術市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球基因轉殖技術市場成長機會（按模式）
    • 全球基因轉殖技術市場成長機會（依方法）
    • 全球基因轉殖技術市場成長機會（按應用）
    • 全球基因轉殖技術市場成長機會（按地區）
  • 全球基因轉殖技術市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球基因轉殖技術市場的容量
    • 全球基因轉殖技術市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Thermo Fisher Scientific
  • QIAGEN
  • Horizon Discovery
  • OriGene Technologies
  • Oxford Biomedica
  • SignaGen Laboratories
  • Vectalys
簡介目錄

Gene Delivery Technologies Trends and Forecast

The future of the global gene delivery technologies market looks promising with opportunities in the gene therapy, cell therapy, vaccines, and research markets. The global gene delivery technologies market is expected to reach an estimated $7.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases, growing demand for targeted therapeutics, and advancements in gene and cell research and therapeutic delivery.

A more than 150-page report is developed to help in your business decisions.

Gene Delivery Technologies by Segment

The study includes a forecast for the global gene delivery technologies by mode, method, application, and region.

Gene Delivery Technologies Market by Mode [Shipment Analysis by Value from 2018 to 2030]:

  • Biological
  • Chemical
  • Physical

Gene Delivery Technologies Market by Method [Shipment Analysis by Value from 2018 to 2030]:

  • Ex Vivo
  • In Vivo
  • In Vitro

Gene Delivery Technologies Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Gene Therapy
  • Cell Therapy
  • Vaccines
  • Research

Gene Delivery Technologies Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Gene Delivery Technologies Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gene delivery technologies companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gene delivery technologies companies profiled in this report include-

  • Thermo Fisher Scientific
  • QIAGEN
  • Horizon Discovery
  • OriGene Technologies
  • Oxford Biomedica
  • SignaGen Laboratories
  • Vectalys

Gene Delivery Technologies Market Insights

Lucintel forecasts that biological will remain the largest segment over the forecast period due to growing number of viral vectors-based R&D programs along high success of Kymriah and Yescarta.

Within this market, gene therapy will remain the largest segment due to increasing adoption of gene-based therapies and growing number of clinical research initiatives.

North America will remain the largest region over the forecast period due to risng number of clinical trials, increasing expenditure of patients on gene therapies, and presence of major players in the region.

Features of the Global Gene Delivery Technologies Market

Market Size Estimates: Gene delivery technologies market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Gene delivery technologies market size by mode, method, application, and region in terms of value ($B).

Regional Analysis: Gene delivery technologies market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different modes, methods, applications, and regions for the gene delivery technologies market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gene delivery technologies market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the gene delivery technologies market size?

Answer: The global gene delivery technologies market is expected to reach an estimated $7.7 billion by 2030.

Q2. What is the growth forecast for gene delivery technologies market?

Answer: The global gene delivery technologies market is expected to grow with a CAGR of 14.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the gene delivery technologies market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases, growing demand for targeted therapeutics, and advancements in gene and cell research and therapeutic delivery.

Q4. What are the major segments for gene delivery technologies market?

Answer: The future of the gene delivery technologies market looks promising with opportunities in the gene therapy, cell therapy, vaccines, and research markets.

Q5. Who are the key gene delivery technologies market companies?

Answer: Some of the key gene delivery technologies companies are as follows:

  • Thermo Fisher Scientific
  • QIAGEN
  • Horizon Discovery
  • OriGene Technologies
  • Oxford Biomedica
  • SignaGen Laboratories
  • Vectalys

Q6. Which gene delivery technologies market segment will be the largest in future?

Answer: Lucintel forecasts that biological will remain the largest segment over the forecast period due to growing number of viral vectors-based R&D programs along high success of Kymriah and Yescarta.

Q7. In gene delivery technologies market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to risng number of clinical trials, increasing expenditure of patients on gene therapies, and presence of major players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the gene delivery technologies market by mode (biological, chemical, and physical), method (ex vivo, in vivo, and in vitro), application (gene therapy, cell therapy, vaccines, and research), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Gene Delivery Technologies Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Gene Delivery Technologies Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Gene Delivery Technologies Market by Mode
    • 3.3.1: Biological
    • 3.3.2: Chemical
    • 3.3.3: Physical
  • 3.4: Global Gene Delivery Technologies Market by Method
    • 3.4.1: Ex vivo
    • 3.4.2: In vivo
    • 3.4.3: In vitro
  • 3.5: Global Gene Delivery Technologies Market by Application
    • 3.5.1: Gene Therapy
    • 3.5.2: Cell Therapy
    • 3.5.3: Vaccines
    • 3.5.4: Research

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Gene Delivery Technologies Market by Region
  • 4.2: North American Gene Delivery Technologies Market
    • 4.2.2: North American Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
  • 4.3: European Gene Delivery Technologies Market
    • 4.3.1: European Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
    • 4.3.2: European Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
  • 4.4: APAC Gene Delivery Technologies Market
    • 4.4.1: APAC Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
    • 4.4.2: APAC Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research
  • 4.5: ROW Gene Delivery Technologies Market
    • 4.5.1: ROW Gene Delivery Technologies Market by Mode: Biological, Chemical, and Physical
    • 4.5.2: ROW Gene Delivery Technologies Market by Application: Gene Therapy, Cell Therapy, Vaccines, and Research

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Gene Delivery Technologies Market by Mode
    • 6.1.2: Growth Opportunities for the Global Gene Delivery Technologies Market by Method
    • 6.1.3: Growth Opportunities for the Global Gene Delivery Technologies Market by Application
    • 6.1.4: Growth Opportunities for the Global Gene Delivery Technologies Market by Region
  • 6.2: Emerging Trends in the Global Gene Delivery Technologies Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Gene Delivery Technologies Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Gene Delivery Technologies Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: QIAGEN
  • 7.3: Horizon Discovery
  • 7.4: OriGene Technologies
  • 7.5: Oxford Biomedica
  • 7.6: SignaGen Laboratories
  • 7.7: Vectalys